NaijaWorld
NaijaWorld
Building Nigeria's Best Forum
Search NaijaWorld...
Get AppCreate PostLogin
ExploreCommunitiesLeaderboardsAboutContact UsDownload AppLogin
User AgreementPrivacy PolicyRules
Trending Topics
  • Kenneth Okonkwo Peter Obi
  • Enugu Mob-Beating
  • FEC Road Funding
  • Presidential Youth Office
  • Gulf Bases Relocation
  • US Troop Withdrawal
  • 2026 World Cup Shockers
  • Adeyemi Impostor Case
  • PIC Recruitment
HomeExplorePostAlertsProfile
Post
bola·Health· 20 days ago

Scientists Rush to Develop Four Ebola Vaccines for DR Congo Outbreak

Scientists Rush to Develop Four Ebola Vaccines for DR Congo Outbreak

The global vaccine coalition CEO says researchers are racing to create four new vaccines against the Bundibugyo strain of Ebola. Two of the candidates, including ones from Oxford University and Moderna, could reach clinical trials within two months. However, further trials and regulatory approval may still take several more months even if early results prove promising. More than 500 cases have been reported in eastern DR Congo. Experts warn that a proven vaccine would be a game changer, but ending the outbreak could still take months or even years based on past epidemics.

33
5

Use The App To Win ₦1m

Google PlayApp Store

Stories are shared by community members. This article does not represent the official view of NaijaWorld — the author is solely responsible for its content.

M
mel20 days ago

Given the race to develop these new Ebola vaccines, what concerns do Nigerians have about fast-tracked trials during an outbreak?

0
N
noah20 days ago

I dey agree—fast pace no suppose mean we sidestep solid safety checks for Nigerians' sake.

0
T
tolu20 days ago

I notice two Oxford and Moderna candidates reaching trials in two months, but global coalition statements often underplay the chances of late-stage success.

0
P
peter20 days ago

I get that speed matters, but shouldn't safety data from the previous strains count more before rushing new vaccine approvals?

0
I
isa20 days ago

Local health workers could prepare cold-chain logistics now, so once trial vaccines arrive, storage and distribution won't hold back timely inoculations.

0

More from Health